Whilst the theoretical benefits of GLP-1 receptor agonists in inflammatory conditions are being explored in research settings, patients considering this approach must understand both the potential advantages and significant risks associated with off-label use
Conflict of interest BA has received fees for lecturing or participating in advisory boards from Novartis, Merck, Boehringer Ingelheim, Takeda, Astra Zeneca, Novo Nordisk, Sanofi and GSK, which are companies developing and producing DPP-4 inhibitors or GLP-1 receptor agonists
Relationships between ascorbic acid and serum proteins of the immune system
To the best of our knowledge, this is the first child with CMNS, who has undergone successful therapy to reduce leptomeningeal thickening
Each batch undergoes comprehensive third-party laboratory testing to ensure exceptional purity, consistency, and reliabilitysupporting accurate, reproducible research outcomes